News

- UBS warns a Supreme Court ruling against Trump's tariffs could force $140B refunds, straining U.S. fiscal resources and prompting potential Fed rate cuts. - The refunds stem from 39% Swiss tariffs deemed potentially unlawful, with fiscal impact equivalent to 7.9% of 2025's projected budget deficit. - Legal challenges highlight executive overreach risks, while reduced tariffs could boost consumer spending and ease inflation, creating room for Fed easing. - Swiss business leaders have lobbied Trump to lowe

- Arm Holdings reported $1.14B Q3 revenue, 34% YoY growth surpassing forecasts, driven by AI/data center demand. - Royalty revenue rose 21% to $620M while licensing revenue jumped 56% to $515M, reflecting strong IP adoption. - Strategic shift to develop full-chip solutions via Compute Sub Systems aims to compete with Nvidia/Amazon in AI hardware. - Parent company SoftBank explored Arm-Marvell merger to strengthen AI infrastructure, highlighting industry consolidation trends. - 20 "buy" ratings and $155 pri

- U.S. household debt hit $18.59 trillion in Q3 2025, driven by rising credit card, student loan, and home equity debt with delinquency rates at multi-year highs. - The Fed initiated rate cuts amid slowing job growth but faces a dilemma: easing economic strain risks inflating a consumer debt bubble while tightening worsens defaults. - Retailers, banks, and auto lenders face fallout as discretionary spending declines and loan defaults rise, while essential goods and debt collectors see increased demand. - P

- Novo Nordisk's $9B Metsera acquisition faces Pfizer lawsuits alleging antitrust violations and breach of contract under U.S. antitrust laws. - Pfizer claims the deal delays GLP-1 competition and binds Metsera to restrictive covenants, while Novo dismisses allegations as "baseless" and confident in antitrust compliance. - Novo cuts $8B annual costs, launches Wegovy pill, and partners with Costco/Walmart to counter 9% market share loss amid U.S. pricing pressures and patent expirations. - The obesity drug

NYC’s new mayor Zohran Mamdani may shift focus from crypto to social policy, creating uncertainty for blockchain firms.

- Bitcoin fell below $108,000 on Nov. 3, 2025, driven by macroeconomic uncertainty, institutional outflows, and whale selling pressures. - Analysts debate if the decline marks the end of a four-year bull cycle or a temporary correction before a year-end rally. - Corporate buyers like Mike Novogratz's firm continued accumulating BTC, contrasting broader market weakness amid a 36% drop risk warning. - Bullish forecasts cite seasonal strength and potential Fed liquidity injections, while technical indicators

- UK strengthens tech leadership through space defense, education tools, and creative campaigns, showcasing multifaceted innovation. - Raytheon UK secures contract to enhance orbital analysis via NORSSTrack software, supporting national space domain awareness and debris monitoring. - University of Kentucky launches Canva Enterprise to standardize branding, enabling staff to create professional materials with shared templates. - Apple UK invites iPad users to design Christmas projections, continuing public

- SAPIEN and GIGGLE faced second-largest crypto liquidations after BTC/ETH, driven by volatile price swings linked to Binance's airdrop and listing speculation. - SAPIEN surged 127% on "Binance HODLer Airdrop" hype but collapsed as leveraged traders faced margin calls amid rapid one-hour $0.32 price spikes. - Analysts highlight market fragility: speculative airdrops and listing rumors trigger explosive gains but expose liquidity risks in leveraged trading environments. - GIGGLE's unclear price drivers sugg